Business Description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
ISIN : CNE1000062J1
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 42.2 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.26 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 17.01 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate | 14.96 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.29 | |||||
9-Day RSI | 53.67 | |||||
14-Day RSI | 54.74 | |||||
6-1 Month Momentum % | 68.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 2.47 | |||||
Cash Ratio | 2.28 | |||||
Days Inventory | 156.66 | |||||
Days Sales Outstanding | 0.17 | |||||
Days Payable | 610.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 8.4 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 65.64 | |||||
Operating Margin % | -51.43 | |||||
Net Margin % | -75.18 | |||||
FCF Margin % | -31.7 | |||||
ROA % | -14.93 | |||||
ROIC % | -8.34 | |||||
ROC (Joel Greenblatt) % | -39.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 73.71 | |||||
PB Ratio | 15.07 | |||||
Price-to-Tangible-Book | 15.6 | |||||
EV-to-EBIT | -141.63 | |||||
EV-to-Forward-EBIT | -52.96 | |||||
EV-to-EBITDA | -153.25 | |||||
EV-to-Revenue | 75.47 | |||||
EV-to-Forward-Revenue | 39.05 | |||||
EV-to-FCF | -238.08 | |||||
Price-to-Net-Current-Asset-Value | 21.96 | |||||
Price-to-Net-Cash | 26.49 | |||||
Earnings Yield (Greenblatt) % | -0.71 | |||||
FCF Yield % | -0.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 512.933 | ||
EPS (TTM) (HK$) | -1.593 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 54.74 | ||
14-Day ATR (HK$) | 15.037649 | ||
20-Day SMA (HK$) | 174.77 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (HK$) | 60.6 - 195 | ||
Shares Outstanding (Mil) | 222.84 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Frequently Asked Questions
What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)'s stock price today?
When is next earnings date of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)?
Does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |